Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062

Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143

Methoden der enzymatischen Analyse

Bergmeyer, H. U. (1962) · Chemie eBooks · Cited by 4,030

Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase

Deng, H., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,479

The control of flux.

KACSER, H., & Ja, B. (1973) · PubMed · Cited by 1,455

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

Wong, P. C., Pardo, C. A., Borchelt, D., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,439

Aging, energy, and oxidative stress in neurodegenerative diseases

Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434

Diseases of the mitochondrial DNA

Wallace, D. C. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.005523 · Cited by 1,319

Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants

Skulachev, V. P. (1996) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500005795 · Cited by 703

Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis

Bowling, A. C., Schulz, J. B., Brown, R. H., & Beal, M. F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07478.x · Cited by 629

Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis

Gianforcaro, A., & Hamadeh, M. J. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12204 · Cited by 61

Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated

Singh, T., Jiao, Y., Ferrando, L. M., Yablonska, S., Li, F., Horoszko, E. C., Lacomis, D., Friedlander, R. M., & Carlisle, D. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-97928-7 · Cited by 55

Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration

Labarre, A., Guitard, E., Tossing, G., Forest, A., Bareke, E., Labrecque, M., Tétreault, M., Ruiz, M., & Parker, J. A. (2022) · Communications Biology · doi:10.1038/s42003-022-04295-8 · Cited by 55

Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study

Al‐Sarraj, S., King, A., Cleveland, M. S., Pradat, P., Corse, A. M., Rothstein, J. D., Leigh, P., Abila, B., Bates, S., Würthner, J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0165-z · Cited by 57

Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis

Siciliano, G., Piazza, S., Carlesi, C., Corona, A., Franzini, M., Alfonso Pompella, C., Malvaldi, G., Mancuso, M., Paolicchi, A., & Murri, L. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0301-1 · Cited by 55

Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation

Jaiswal, M. K. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-26 · Cited by 56

Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis

Sassani, M., Alix, J. J. P., McDermott, C. J., Baster, K., Hoggard, N., Wild, J. M., Mortiboys, H., Shaw, P. J., Wilkinson, I. D., & Jenkins, T. M. (2020) · Brain · doi:10.1093/brain/awaa340 · Cited by 53

AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis

Perera, N. D., & Turner, B. J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1665-3 · Cited by 51

Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome

Martin, L. J., & Wong, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.592851 · Cited by 49

Effect of Creatine Supplementation on Metabolite Levels in ALS Motor Cortices

Vielhaber, S., Kaufmann, J., Kanowski, M., Sailer, M., Feistner, H., Tempelmann, C., Elger, C. E., Heinze, H., & Kunz, W. S. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7797 · Cited by 49

Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system

Bertamini, M., Marzani, B., Guarneri, R., Guarneri, P., Bigini, P., Mennini, T., & Curti, D. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02299.x · Cited by 48

The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis

Ngo, S. T., & Steyn, F. J. (2015) · Cell Regeneration · doi:10.1186/s13619-015-0019-6 · Cited by 46

Simultaneous evaluation of substrate-dependent oxygen consumption rates and mitochondrial membrane potential by TMRM and safranin in cortical mitochondria

Chowdhury, S. R., Djordjevic, J., Albensi, B. C., & Fernyhough, P. (2015) · Bioscience Reports · doi:10.1042/bsr20150244 · Cited by 46

Expression of zinc-deficient human superoxide dismutase in Drosophila neurons produces a locomotor defect linked to mitochondrial dysfunction

Bahadorani, S., Mukai, S. T., Rabie, J., Beckman, J. S., Phillips, J. P., & Hilliker, A. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.024 · Cited by 45

Mitochondria-Targeted Catalase Reverts the Neurotoxicity of hSOD1G93A Astrocytes without Extending the Survival of ALS-Linked Mutant hSOD1 Mice

Pehar, M., Beeson, G. C., Beeson, C., Johnson, J. A., & Vargas, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103438 · Cited by 44

Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in wobbler mice

Dave, K. R., Prado, R., Busto, R., Raval, A. P., Bradley, W. G., Torbati, D., & Pérez‐Pinzón, M. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00244-6 · Cited by 44

Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice

Leclerc, N., Ribera, F., Zoll, J., Warter, J., Poindron, P., Lampert, E., & Borg, J. (2001) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00240-1 · Cited by 44

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis

Lépine, S., Castellanos‐Montiel, M. J., & Durcan, T. M. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00331-z · Cited by 46

Skeletal muscle fiber function and rate of disease progression in amyotrophic lateral sclerosis

Krivickas, L. S., Yang, J., Kim, S., & Frontera, W. R. (2002) · Muscle & Nerve · doi:10.1002/mus.10257 · Cited by 43

Serum levels of coenzyme Q 10 in patients with amyotrophic lateral sclerosis

Molina, J. A., de Bustos, F., Jiménez‐Jiménez, F. J., Gómez-Escalonilla, C., García‐Redondo, A., Esteban, J., Guerrero-Sola, A., del Hoyo, P., Martínez‐Salio, A., Ramírez-Ramos, C., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070050 · Cited by 43

Impaired oxidative metabolism in exercising muscle from ALS patients

Siciliano, G., Pastorini, E., Pasquali, L., Manca, M. L., Iudice, A., & Murri, L. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00620-7 · Cited by 43

6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson’s disease: respirometric, histological, and behavioral analyses

Kupsch, A. R., Schmidt, W., Gizatullina, Z. Z., Dębska–Vielhaber, G., Voges, J., Striggow, F., Panther, P., Schwegler, H., Heinze, H., Vielhaber, S., et al. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1185-3 · Cited by 42

Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction

Corti, S. P., Donadoni, C., Ronchi, D., Bordoni, A., Fortunato, F., Santoro, D., Bo, R. D., Lucchini, V., Crugnola, V., Papadimitriou, D. A., et al. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.09.030 · Cited by 41

Role of mitochondria in amyotrophic lateral sclerosis

Swerdlow, R. H., Parks, J. K., Pattee, G. L., & Parker, W. D. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515179 · Cited by 41

Mitochondrial Perturbance and Execution of Apoptosis in Platelet Mitochondria of Patients With Amyotrophic Lateral Sclerosis

Shrivastava, M., Vivekanandhan, S., Pati, U., Behari, M., & Das, T. K. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.537416 · Cited by 40

Swim Training Modulates Skeletal Muscle Energy Metabolism, Oxidative Stress, and Mitochondrial Cholesterol Content in Amyotrophic Lateral Sclerosis Mice

Flis, D. J., Dzik, K. P., Kaczor, J. J., Hałoń, M., Antosiewicz, J., Wieckowski, M. R., & Ziółkowski, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5940748 · Cited by 39

Functional skeletal muscle model derived from SOD1-mutant ALS patient iPSCs recapitulates hallmarks of disease progression

Badu-Mensah, A., Guo, X., McAleer, C. W., Rumsey, J. W., & Hickman, J. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-70510-3 · Cited by 39

The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice

de Aguilar, J. G., Dupuis, L., Oudart, H., & Loeffler, J. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.03.003 · Cited by 39

Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis

Belosludtseva, N. V., Matveeva, L. A., & Belosludtsev, K. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316833 · Cited by 40

Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System

Golomb, B. A., Verden, A., Messner, A. K., Koslik, H. J., & Hoffman, K. B. (2018) · Drug Safety · doi:10.1007/s40264-017-0620-4 · Cited by 38

Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis

Cacabelos, D., Ayala, V., Granado‐Serrano, A. B., Jové, M., Torres, P., Boada, J., Cabré, R., Ramírez‐Núñez, O., Gonzalo‐Benito, H., Soler-Cantero, A., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.007 · Cited by 39

Synaptic Failure: Focus in an Integrative View of ALS

Casas, C., Manzano, R., Vaz, A. R., Osta, R., & Brites, D. M. T. O. (2015) · Brain Plasticity · doi:10.3233/bpl-140001 · Cited by 39

Shedding light on mitochondrial function by real time monitoring of NADH fluorescence: II: human studies

Mayevsky, A., & Barbiro‐Michaely, E. (2012) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-012-9413-6 · Cited by 37

Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment

Pattee, G. L., Post, G. R., Gerber, R. E., & Bennett, J. P. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310012736 · Cited by 36

Retinal flavoprotein autofluorescence as a measure of retinal health.

Elner, S. G., Elner, V. M., Field, M. G., Park, S. L., Heckenlively, J. R., & Petty, H. R. (2008) · PubMed Central · Cited by 36

Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases

H. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35

New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders

Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34

What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy

Manzano, R., Toivonen, J. M., Moreno‐Martínez, L., de la Torre, M., Moreno‐García, L., López‐Royo, T., Molina, N., Zaragoza, P., Calvo, A. C., & Osta, R. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15276 · Cited by 34

Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats

Smittkamp, S. E., Spalding, H. N., Brown, J. W., Gupte, A. A., Chen, J., Nishimune, H., Geiger, P. C., & Stanford, J. A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.007 · Cited by 35

Dysfunctional mitochondrial respiration in the wobbler mouse brain

Xu, G.-P., Dave, K. R., Moraes, C. T., Busto, R., Sick, T. J., Bradley, W. G., & Pérez‐Pinzón, M. A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01575-0 · Cited by 34

Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis

Richardson, P. J., Smith, D. P., de Giorgio, A., Snetkov, X., Almond-Thynne, J., Cronin, S., Mead, R. J., McDermott, C. J., & Shaw, P. J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00380-y · Cited by 35

Axonal degeneration in the peripheral nervous system: Implications for the pathogenesis of amyotrophic lateral sclerosis

Hayes, L. R., Brotherton, T. E., & Glass, J. D. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.05.001 · Cited by 37

Potential benefits of medium chain fatty acids in aging and neurodegenerative disease

Dunn, E., Zhang, B., Sahota, V. K., & Augustin, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1230467 · Cited by 38

Translating preclinical insights into effective human trials in ALS

DiBernardo, A., & Cudkowicz, M. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.007 · Cited by 34

Evaluation of quantitative and qualitative aspects of mitochondrial function in human skeletal and cardiac muscles

N’guessan, B. B., Zoll, J., Ribera, F., Ponsot, E., Lampert, E., Ventura‐Clapier, R., Veksler, V., & Mettauer, B. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000009874.14649.ca · Cited by 33

Early mitochondrial dysfunction occurs in motor cortex and spinal cord at the onset of disease in the Wobbler mouse

Dave, K. R., Bradley, W. G., & Pérez‐Pinzón, M. A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00091-8 · Cited by 34

Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity

McCombe, P., Wray, N. R., & Henderson, R. D. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1273772 · Cited by 35

Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis

Cunha‐Oliveira, T., Montezinho, L., Simões, R. F., de Carvalho, M., Ferreiro, E. B., & Silva, F. S. G. (2024) · Cells · doi:10.3390/cells13030248 · Cited by 34

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis

Kirk, S. E., Tracey, T. J., Steyn, F. J., & Ngo, S. T. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00191 · Cited by 38

Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?

Quessada, C., Bouscary, A., René, F., Valle, C., Ferri, A., Ngo, S. T., & Loeffler, J. (2021) · Cells · doi:10.3390/cells10061449 · Cited by 33

Misfolded SOD1 Accumulation and Mitochondrial Association Contribute to the Selective Vulnerability of Motor Neurons in Familial ALS: Correlation to Human Disease

Abu‐Hamad, S., Kahn, J., Leyton-Jaimes, M. F., Rosenblatt, J. D., & Israelson, A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00140 · Cited by 32

Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions

Ngo, S. T., Mi, J. D., Henderson, R. D., McCombe, P., & Steyn, F. J. (2017) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s120607 · Cited by 31

Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis

Nelson, A. T., & Trotti, D. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01262-3 · Cited by 31

Mitochondrial DNA from platelets of sporadic ALS patients restores normal respiratory functions in ρ0 cells

Gajewski, C. D., Lin, M. T. S., Cudkowicz, M., Beal, M. F., & Manfredi, G. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00022-5 · Cited by 30

Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients

Sorarú, G., Vergani, L., Fedrizzi, L., D’Ascenzo, C., Polo, A., Bernazzi, B., & Angelini, C. I. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00791.x · Cited by 29

Neurodegenerative disorders, metabolic icebergs, and mitohormesis

Phillips, M. C. L., & Picard, M. A. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00435-8 · Cited by 31

Metabolic Consequences of the CytochromecOxidase Deficiency in Brain of Copper‐Deficient MovbrMice

Kunz, W. S., Kuznetsov, A. V., Clark, J. F., Tracey, I., & Elger, C. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721580.x · Cited by 28

Impairment of mitochondrial oxidative phosphorylation in skin fibroblasts of SALS and FALS patients is rescued by in vitro treatment with ROS scavengers

Dębska–Vielhaber, G., Miller, I., Peeva, V., Zuschratter, W., Walczak, J., Schreiber, S., Petri, S., Machts, J., Vogt, S., Szczepanowska, J., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113620 · Cited by 28

New insights into the skeletal muscle phenotype of equine motor neuron disease: a quantitative approach

Palencia, P., QUIROZ‐ROTHE, E., & Rivero, J. L. L. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0940-1 · Cited by 26

The "new" mitochondrial disorders

Schapira, A. H. V. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.144 · Cited by 26

Detection of Respiratory Chain Defects in Cultivated Skin Fibroblasts and Skeletal Muscle of Patients with Parkinson's Disease

Wiedemann, F. R., Winkler, K., Lins, H., Wallesch, C., & Kunz, W. S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07870.x · Cited by 25

Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis

Lanznaster, D., Bruno, C., Bourgeais, J., Emond, P., Zemmoura, I., Lefèvre, A., Reynier, P., Eymieux, S., Blanchard, E., Vourc’h, P., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10061307 · Cited by 24

Amyotrophic Lateral Sclerosis

Dib, M. (2003) · Drugs · doi:10.2165/00003495-200363030-00004 · Cited by 24

Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship

Candelise, N., Salvatori, I., Scaricamazza, S., Nesci, V., Zenuni, H., Ferri, A., & Valle, C. (2022) · Metabolites · doi:10.3390/metabo12030233 · Cited by 25

Quantity and Activation of Myofiber-Associated Satellite Cells in a Mouse Model of Amyotrophic Lateral Sclerosis

Manzano, R., Toivonen, J. M., Calvo, A. C., Oliván, S., Zaragoza, P., Muñoz, M. J., Montarras, D., & Osta, R. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9268-0 · Cited by 23

Amyotrophic Lateral Sclerosis

Perry, J. J. P., Shin, D. S., & Tainer, J. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_2 · Cited by 23

Limited diagnostic value of enzyme analysis in patients with mitochondrial tRNA mutations

Wibrand, F., Jeppesen, T. D., Frederiksen, A. L., Olsen, D. B., Dunø, M., Schwartz, M., & Vissing, J. (2009) · Muscle & Nerve · doi:10.1002/mus.21541 · Cited by 22

Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases

Yusoff, A. A. M., & Khair, S. Z. N. M. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0080 · Cited by 23

Polyamine metabolism dysregulation contributes to muscle fiber vulnerability in ALS

Ruggieri, V., Scaricamazza, S., Bracaglia, A., D’Ercole, C., Parisi, C., D’Angelo, P., Proietti, D., Cappelletti, C., Macone, A., Lozanoska‐Ochser, B., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115123 · Cited by 22

Sigma-1 Receptor in Motoneuron Disease

Mancuso, R., & Navarro, X. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50174-1_16 · Cited by 22

Lack of Effect of Methylene Blue in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis

Lougheed, R., & Turnbull, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023141 · Cited by 20

Amyotrophic lateral sclerosis: contemporary concepts in etiopathogenesis and pharmacotherapy

Strong, M. J. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.12.1593 · Cited by 20

Is ALS a systemic disorder? Evidence from muscle mitochondria

Appel, S. H. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.025 · Cited by 20

MITOCHONDRIOPATHY MIMICKING AMYOTROPHIC LATERAL SCLEROSIS

Finsterer, J. (2003) · The Neurologist · doi:10.1097/01.nrl.0000038589.58012.a8 · Cited by 20

Creatine and coenzyme Q10 in the treatment of ALS

Strong, M. J., & Pattee, G. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515665 · Cited by 20

Mitochondrial Dysfunction during the Early Stages of Excitotoxic Spinal Motor Neuron Degeneration in Vivo

Santa-Cruz, L. D., Guerrero‐Castillo, S., Uribe‐Carvajal, S., & Tapia, R. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00032 · Cited by 19

Reduced exercise capacity in early-stage amyotrophic lateral sclerosis: Role of skeletal muscle

Mezzani, A., Pisano, F., Cavalli, A., Tommasi, M. A., Corrà, U., Colombo, S., Grassi, B., Marzorati, M., Porcelli, S., Morandi, L. O., et al. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.601463 · Cited by 19

Mitochondriopathy as a differential diagnosis of amyotrophic lateral sclerosis

Finsterer, J. (2002) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608202760839008 · Cited by 19

Inflammatory cytokines increase mitochondrial damage in motoneuronal cells expressing mutant SOD1

Ferri, A., Nencini, M., Cozzolino, M., Carrara, P., Moreno, S., & Carrı̀, M. T. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.004 · Cited by 17

Neuroprotective Effect of Human Adipose Stem Cell-Derived Extract in Amyotrophic Lateral Sclerosis

Jeon, G. S., Im, W., Shim, Y., Lee, M., Kim, M.-J., Hong, Y., Seong, S., Kim, M., & Sung, J. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1774-z · Cited by 16

Mitochondrial genome aberrations in skeletal muscle of patients with motor neuron disease

Artuso, L., Zoccolella, S., Favia, P., Amati, A., Capozzo, R., Logroscino, G., Serlenga, L., Simone, I. L., Gasparre, G., & Petruzzella, V. (2012) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.735239 · Cited by 16

Morphological abnormalities in mitochondria of the skin of patients with sporadic amyotrophic lateral sclerosis

Rodriguez, G. E., González, D. M. C., Gargiulo-Monachelli, G. M., Costa, J. J. L., Nicola, A. F. D., & Sica, R. E. P. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012000100010 · Cited by 16

Mitochondrial disfunction as a cause of ALS.

Pizzuti, A., & Petrucci, S. (2011) · PubMed · doi:10.4449/aib.v149i1.1266 · Cited by 15

Multidisciplinary Interventions in Motor Neuron Disease

Williams, U. E., Philip-Ephraim, E. E., & Oparah, S. K. (2014) · Journal of Neurodegenerative Diseases · doi:10.1155/2014/435164 · Cited by 14

Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach

Kumar, A., Ghosh, D., & Singh, R. L. (2013) · Journal of Biomarkers · doi:10.1155/2013/538765 · Cited by 15

Increased sensitivity of myoblasts to oxidative stress in amyotrophic lateral sclerosis peripheral tissues

Bradley, L. J., Taanman, J., Kallis, C., & Orrell, R. W. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.007 · Cited by 14

Eosinophilic Enteritis in Horses with Motor Neuron Disease

de Castro, E. D., Zafra, R., Acevedo, L. M., Pérez, J., Acosta, I., Rivero, J. L. L., & Aguilera‐Tejero, E. (2016) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.13944 · Cited by 14

The Cellular and Molecular Signature of ALS in Muscle

Anakor, E., Duddy, W. J., & Duguez, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111868 · Cited by 14

Mitochondrial Dysfunction in Sporadic Amyotrophic Lateral Sclerosis Patients: Insights from High-Resolution Respirometry

Parvanovova, P., Evinová, A., Grofik, M., Hnilicová, P., Tatarková, Z., & Koprušáková, M. T. (2024) · Biomedicines · doi:10.3390/biomedicines12061294 · Cited by 14

Limiting iron availability confers neuroprotection from chronic mild carbon monoxide exposure in the developing auditory system of the rat

Webber, D. S., Lopez, I., Korsak, R. A., Hirota, S. K., Acuña, D., & Edmond, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20495 · Cited by 13

An Insight into Ultrastructural and Morphological Alterations of Platelets in Neurodegenerative Diseases

Shrivastava, M., & Vivekanandhan, S. (2011) · Ultrastructural Pathology · doi:10.3109/01913123.2011.553350 · Cited by 13

Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis and Spinal Muscular Atrophy

Strong, M. J., Hortobágyi, T., Okamoto, K., & Kato, S. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch44 · Cited by 13

Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients

Mathur, D., Riffo‐Campos, Á. L., Castillo, J., Haines, J. D., Vidaurre, Ó. G., Zhang, F., Ferrer, F. C., Casaccia, P., Casanova, B., & López‐Rodas, G. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00209 · Cited by 12

Sporadic amyotrophic lateral sclerosis: new hypothesis regarding its etiology and pathogenesis suggests that astrocytes might be the primary target hosting a still unknown external agent

Sica, R. E. P., Nicola, A. F. D., Deniselle, M. C. G., Rodriguez, G. E., Gargiulo-Monachelli, G. M., Peralta, L. M., & Bettini, M. (2011) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2011000500023 · Cited by 10

Neuroprotective Effect of the Novel Compound ITH33/IQM9.21 Against Oxidative Stress and Na+ and Ca2+ Overload in Motor Neuron-like NSC-34 Cells

Moreno‐Ortega, A. J., Al-achbili, L. M., Alonso, E., Rı́os, C. D. L., Garcı́a, A. G., Ruíz‐Nuño, A., & Cano‐Abad, M. F. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9623-7 · Cited by 11

Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord

Tungtur, S. K., Wilkins, H., Rogers, R. S., Badawi, Y., Sage, J. M., Aǵbaş, A., Jawdat, O., Barohn, R. J., Swerdlow, R. H., & Nishimune, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-90438-6 · Cited by 11

Mitochondria and amyotrophic lateral sclerosis

Orrell, R. W., & Schapira, A. H. V. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53015-4 · Cited by 11

Altered calcium homeostasis in ALS as a target for therapy

Appel, S. H. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820052415754-1 · Cited by 11

Peroxisome Proliferator Activator Receptor Gamma Coactivator-1α Overexpression in Amyotrophic Lateral Sclerosis: A Tale of Two Transgenics

Varghese, M., Zhao, W., Yemul, S., Vempati, P., Radu, A., Simkovic, S., & Pasinetti, G. M. (2020) · Biomolecules · doi:10.3390/biom10050760 · Cited by 10

Targeting mitochondrial Ca2+ uptake for the treatment of amyotrophic lateral sclerosis

Zhong, R., Rua, M. T., & Wei‐LaPierre, L. (2023) · The Journal of Physiology · doi:10.1113/jp284143 · Cited by 12

Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis

Vielhaber, S. (2000) · Brain · doi:10.1093/brain/123.7.1339 · Cited by 268

Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis

Vielhaber, S., Winkler, K., Kirches, E., Kunz, D., Büchner, M., Feistner, H., Elger, C. E., Ludolph, A. C., Riepe, M. W., & Kunz, W. S. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00236-1 · Cited by 121

Mitochondrial Respiratory Chain Dysfunction in Muscle From Patients With Amyotrophic Lateral Sclerosis

Crugnola, V., Lamperti, C., Lucchini, V., Ronchi, D., Peverelli, L., Prelle, A. C., Sciacco, M., Bordoni, A., Fassone, E., Fortunato, F., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.128 · Cited by 152

Mitochondrial dysfunction in amyotrophic lateral sclerosis also affects skeletal muscle

Dupuis, L., de Aguilar, J. G., Echaniz‐Laguna, A., & Loeffler, J. (2006) · Muscle & Nerve · doi:10.1002/mus.20566 · Cited by 17

Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies

Krasnianski, A., Deschauer, M., Neudecker, S., Gellerich, F. N., Müller, T., Schoser, B. G. H., Krasnianski, M., & Zierz, S. (2005) · Brain · doi:10.1093/brain/awh540 · Cited by 94